Skip to main content
. 2020 Oct 6;4(19):4802–4811. doi: 10.1182/bloodadvances.2020002183

Table 5.

Disease response

Response TN CLL/SLL (n = 20) R/R CLL/SLL (n = 25) R/R FL (n = 36)
ORR 20 (100) 23 (92) 26 (72)
Best response
 CR 6 (30) 7 (28) 14 (39)
 PR 14 (70) 16 (64) 12 (33)
Stable disease 0 2 (8) 6 (17)
PD 0 0 4 (11)
ORR for del(17p)/p53 mutation (n = 16) 6 of 6 (100) 8 of 10 (80)
Follow-up period, mo
 Median 29 29 20
 Range 14-35 8-37 2-37

Values are n (%) except as noted.

PR, partial response.